# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5252366 | F | Antimicrobial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 18 hrs by CLSI protocol based two fold serial dilution method | Escherichia coli | 21 | organism-based format | Scientific Literature | ||
2. | ALA5252367 | F | Antimicrobial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in microbial growth incubated for 18 hrs by CLSI protocol based two fold serial dilution method | Staphylococcus aureus | 21 | organism-based format | Scientific Literature | ||
3. | ALA5252368 | F | Antimicrobial activity against Candida albicans SC5314 assessed as reduction in microbial growth incubated for 48 hrs by CLSI protocol based broth microdilution method | Candida albicans | 20 | organism-based format | Scientific Literature | ||
4. | ALA5252369 | F | Antimicrobial activity against clinical isolate Candida utilis SVB-Y1 assessed as reduction in microbial growth incubated for 48 hrs by CLSI protocol based broth microdilution method | Cyberlindnera jadinii | 20 | organism-based format | Scientific Literature | ||
5. | ALA5252370 | F | Antimicrobial activity against clinical isolate Aspergillus fumigatus SVB-F136 assessed as reduction in microbial growth incubated for 48 hrs by CLSI protocol based broth microdilution method | Aspergillus fumigatus | 20 | organism-based format | Scientific Literature | ||
6. | ALA5252371 | T | Hemolytic activity in human RBC assessed as hemolysis rate at 100 uM incubated for 45 mins by spectrophotometric assay relative to control | Homo sapiens | 11 | cell-based format | Scientific Literature |